- Home
- NOG vs ZLAB Comparison
NOG vs ZLAB Comparison
Compare NOG & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOG
- ZLAB
- Stock Information
- Founded
- NOG 2006
- ZLAB 2013
- Country
- NOG United States
- ZLAB China
- Employees
- NOG N/A
- ZLAB N/A
- Industry
- NOG Oil & Gas Production
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- NOG Energy
- ZLAB Health Care
- Exchange
- NOG Nasdaq
- ZLAB Nasdaq
- Market Cap
- NOG 3.6B
- ZLAB 3.5B
- IPO Year
- NOG N/A
- ZLAB 2017
- Fundamental
- Price
- NOG $26.54
- ZLAB $29.24
- Analyst Decision
- NOG Buy
- ZLAB Buy
- Analyst Count
- NOG 7
- ZLAB 4
- Target Price
- NOG $42.14
- ZLAB $47.37
- AVG Volume (30 Days)
- NOG 1.8M
- ZLAB 1.2M
- Earning Date
- NOG 04-29-2025
- ZLAB 05-08-2025
- Dividend Yield
- NOG 6.80%
- ZLAB N/A
- EPS Growth
- NOG 3.91
- ZLAB N/A
- EPS
- NOG 6.43
- ZLAB N/A
- Revenue
- NOG $2,067,269,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- NOG $13.72
- ZLAB $44.43
- Revenue Next Year
- NOG $4.78
- ZLAB $48.68
- P/E Ratio
- NOG $4.12
- ZLAB N/A
- Revenue Growth
- NOG 12.54
- ZLAB 43.72
- 52 Week Low
- NOG $19.88
- ZLAB $15.65
- 52 Week High
- NOG $44.31
- ZLAB $39.77
- Technical
- Relative Strength Index (RSI)
- NOG 56.10
- ZLAB 42.71
- Support Level
- NOG $23.94
- ZLAB $27.61
- Resistance Level
- NOG $24.99
- ZLAB $32.02
- Average True Range (ATR)
- NOG 1.04
- ZLAB 1.23
- MACD
- NOG 0.50
- ZLAB -0.18
- Stochastic Oscillator
- NOG 87.97
- ZLAB 23.41
About NOG Northern Oil and Gas Inc.
Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. Company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), and the Appalachian Basin (Pennsylvania and Ohio).
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.